- Home
- MDXG vs CNNE Comparison
MDXG vs CNNE Comparison
Compare MDXG & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXG
- CNNE
- Stock Information
- Founded
- MDXG 2006
- CNNE 2014
- Country
- MDXG United States
- CNNE United States
- Employees
- MDXG N/A
- CNNE N/A
- Industry
- MDXG Biotechnology: Pharmaceutical Preparations
- CNNE Restaurants
- Sector
- MDXG Health Care
- CNNE Consumer Discretionary
- Exchange
- MDXG Nasdaq
- CNNE Nasdaq
- Market Cap
- MDXG 1.2B
- CNNE 1.1B
- IPO Year
- MDXG N/A
- CNNE N/A
- Fundamental
- Price
- MDXG $7.50
- CNNE $18.67
- Analyst Decision
- MDXG Strong Buy
- CNNE Buy
- Analyst Count
- MDXG 3
- CNNE 2
- Target Price
- MDXG $12.00
- CNNE $22.50
- AVG Volume (30 Days)
- MDXG 527.3K
- CNNE 904.0K
- Earning Date
- MDXG 04-29-2025
- CNNE 05-08-2025
- Dividend Yield
- MDXG N/A
- CNNE 2.60%
- EPS Growth
- MDXG N/A
- CNNE N/A
- EPS
- MDXG 0.28
- CNNE N/A
- Revenue
- MDXG $348,879,000.00
- CNNE $452,500,000.00
- Revenue This Year
- MDXG $10.09
- CNNE N/A
- Revenue Next Year
- MDXG $11.77
- CNNE $2.01
- P/E Ratio
- MDXG $27.14
- CNNE N/A
- Revenue Growth
- MDXG 8.52
- CNNE N/A
- 52 Week Low
- MDXG $5.47
- CNNE $15.99
- 52 Week High
- MDXG $10.14
- CNNE $22.99
- Technical
- Relative Strength Index (RSI)
- MDXG 36.84
- CNNE 53.77
- Support Level
- MDXG $7.41
- CNNE $18.24
- Resistance Level
- MDXG $8.12
- CNNE $20.12
- Average True Range (ATR)
- MDXG 0.23
- CNNE 0.68
- MACD
- MDXG -0.03
- CNNE 0.21
- Stochastic Oscillator
- MDXG 12.50
- CNNE 64.89
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.